Molina Healthcare (NYSE:MOH) Issues FY 2025 Earnings Guidance

Molina Healthcare (NYSE:MOH - Get Free Report) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided EPS guidance of 21.500-22.500 for the period, compared to the consensus EPS estimate of 24.480. The company issued revenue guidance of -. Molina Healthcare also updated its Q2 2025 guidance to 5.500-5.500 EPS.

Molina Healthcare Price Performance

Shares of NYSE:MOH traded down $1.76 during midday trading on Tuesday, hitting $230.85. 854,137 shares of the stock were exchanged, compared to its average volume of 709,472. Molina Healthcare has a twelve month low of $229.85 and a twelve month high of $365.23. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.87. The company has a 50 day moving average price of $298.72 and a 200-day moving average price of $304.67. The stock has a market cap of $12.51 billion, a P/E ratio of 11.15, a PEG ratio of 0.87 and a beta of 0.55.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, beating the consensus estimate of $5.96 by $0.12. Molina Healthcare had a net margin of 2.81% and a return on equity of 28.38%. The business had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same period in the prior year, the business earned $5.73 earnings per share. The company's quarterly revenue was up 12.2% on a year-over-year basis. On average, research analysts forecast that Molina Healthcare will post 24.4 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Guggenheim assumed coverage on Molina Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating for the company. Wall Street Zen lowered Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Morgan Stanley assumed coverage on shares of Molina Healthcare in a research note on Monday, June 9th. They issued an "overweight" rating and a $364.00 target price for the company. Mizuho raised their price target on shares of Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Finally, Truist Financial boosted their price objective on shares of Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a research report on Friday, April 11th. Ten investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $364.21.

Insider Buying and Selling

In other news, Director Richard M. Schapiro sold 669 shares of the business's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director directly owned 11,244 shares of the company's stock, valued at $3,603,702. The trade was a 5.62% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Joseph M. Zubretsky sold 87,500 shares of Molina Healthcare stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the transaction, the chief executive officer owned 257,715 shares in the company, valued at $82,484,262.90. The trade was a 25.35% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.26% of the company's stock.

Institutional Investors Weigh In On Molina Healthcare

Several institutional investors have recently bought and sold shares of MOH. Baird Financial Group Inc. purchased a new position in shares of Molina Healthcare in the 1st quarter valued at $210,000. NewEdge Advisors LLC grew its stake in shares of Molina Healthcare by 33.4% in the first quarter. NewEdge Advisors LLC now owns 1,106 shares of the company's stock valued at $364,000 after buying an additional 277 shares in the last quarter. Jones Financial Companies Lllp raised its holdings in shares of Molina Healthcare by 713.3% during the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company's stock valued at $544,000 after buying an additional 1,448 shares during the period. Focus Partners Wealth raised its holdings in shares of Molina Healthcare by 82.7% during the 1st quarter. Focus Partners Wealth now owns 3,749 shares of the company's stock valued at $1,235,000 after buying an additional 1,697 shares during the period. Finally, Woodline Partners LP acquired a new position in Molina Healthcare during the 1st quarter worth approximately $1,541,000. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.